{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:44:23Z","timestamp":1791215063418,"version":"4.1.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pharep.2015.12.008","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T10:38:57Z","timestamp":1452508737000},"page":"570-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":192,"title":["Regulation of sphingomyelin metabolism"],"prefix":"10.1007","volume":"68","author":[{"given":"Kamil","family":"Bienias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fiedorowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sadowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Prokopiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4926-3405","authenticated-orcid":false,"given":"Halina","family":"Car","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib0990","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1529\/biophysj.105.075150","article-title":"Sphingomyelin structure influences the lateral diffusion and raft formation in lipid bilayers","volume":"90","author":"Filippov","year":"2006","journal-title":"Biophys J"},{"key":"10.1016\/j.pharep.2015.12.008_bib0995","series-title":"An introduction to biological membranes from bilayers to rafts","author":"Stillwell","year":"2013"},{"issue":"12","key":"10.1016\/j.pharep.2015.12.008_bib1000","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/(SICI)1096-9888(199812)33:12<1192::AID-JMS735>3.0.CO;2-J","article-title":"Molecular species of sphingomyelin: determination by high-performance liquid chromatography\/mass spectrometry with electrospray and high-performance liquid chromatography\/tandem mass spectrometry with atmospheric pressure chemical ionization","volume":"33","author":"Karlsson","year":"1998","journal-title":"J Mass Spectrom"},{"issue":"25","key":"10.1016\/j.pharep.2015.12.008_bib1005","doi-asserted-by":"crossref","first-page":"18141","DOI":"10.1074\/jbc.M700708200","article-title":"Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells","volume":"282","author":"Furland","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-5793(02)03406-3","article-title":"Membrane properties of sphingomyelins","volume":"531","author":"Ramstedt","year":"2002","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1015","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/S0006-3495(01)76203-0","article-title":"Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species","volume":"80","author":"Kuikka","year":"2001","journal-title":"Biophys J"},{"issue":"31","key":"10.1016\/j.pharep.2015.12.008_bib1020","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1021\/bi00245a013","article-title":"Interaction of cholesterol with sphingomyelin in bilayer membranes: evidence that the hydroxy group of sphingomyelin does not modulate the rate of cholesterol exchange between vesicles","volume":"30","author":"Kan","year":"1991","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0006-3495(90)82444-9","article-title":"Elastic deformation and failure of lipid bilayer membranes containing cholesterol","volume":"58","author":"Needham","year":"1990","journal-title":"Biophys J"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1030","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1074\/jbc.273.2.1150","article-title":"Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains","volume":"273","author":"Schroeder","year":"1998","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.pharep.2015.12.008_bib1035","doi-asserted-by":"crossref","first-page":"21136","DOI":"10.1074\/jbc.M010666200","article-title":"Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro","volume":"276","author":"Prinetti","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0005-2760(91)90184-J","article-title":"Intracellular transport and metabolism of sphingomyelin","volume":"1082","author":"Koval","year":"1991","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0006-3495(99)77254-1","article-title":"Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length","volume":"76","author":"Ramstedt","year":"1999","journal-title":"Biophys J"},{"issue":"39","key":"10.1016\/j.pharep.2015.12.008_bib1050","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1021\/bi00205a013","article-title":"Interaction of cholesterol with sphingomyelin in monolayers and vesicles","volume":"33","author":"Bittman","year":"1994","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1055","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.bbamem.2010.07.006","article-title":"Sphingomyelin analogs with branched N-acyl chains: the position of branching dramatically affects acyl chain order and sterol interactions in bilayer membranes","volume":"1798","author":"Jaikishan","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1060","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0006-3495(99)76997-3","article-title":"Comparison of the biophysical properties of racemic and d-erythro-N-acyl sphingomyelins","volume":"77","author":"Ramstedt","year":"1999","journal-title":"Biophys J"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/bj20020503","article-title":"Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering","volume":"369","author":"Bini","year":"2003","journal-title":"Biochem J"},{"issue":"23","key":"10.1016\/j.pharep.2015.12.008_bib1070","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1074\/jbc.R000005200","article-title":"Structure and function of sphingolipid- and cholesterol-rich membrane rafts","volume":"275","author":"Brown","year":"2000","journal-title":"J Biol Chem"},{"issue":"36","key":"10.1016\/j.pharep.2015.12.008_bib1075","doi-asserted-by":"crossref","first-page":"27299","DOI":"10.1016\/S0021-9258(19)74249-5","article-title":"Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ","volume":"268","author":"Merrill","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1080","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1016\/S0021-9258(17)41738-8","article-title":"Localization of O-glycan initiation, sphingomyelin synthesis, and glucosylceramide synthesis in Vero cells with respect to the endoplasmic reticulum-Golgi intermediate compartment","volume":"269","author":"Schweizer","year":"1994","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.200105033","article-title":"Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast","volume":"155","author":"Funato","year":"2001","journal-title":"J Cell Biol"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2183\/pjab.86.426","article-title":"Intracellular trafficking of ceramide by ceramide transfer protein","volume":"86","author":"Hanada","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.200807176","article-title":"Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice","volume":"184","author":"Wang","year":"2009","journal-title":"J Cell Biol"},{"issue":"15","key":"10.1016\/j.pharep.2015.12.008_bib1100","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1016\/S0021-9258(19)38937-9","article-title":"Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus","volume":"265","author":"Futerman","year":"1990","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1388-1981(00)00054-8","article-title":"Sphingolipid transport in eukaryotic cells","volume":"1486","author":"van Meer","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"10.1016\/j.pharep.2015.12.008_bib1110","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1016\/S0021-9258(18)93007-3","article-title":"Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs","volume":"266","author":"Schuchman","year":"1991","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12017-010-8120-z","article-title":"Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses","volume":"12","author":"Wu","year":"2010","journal-title":"Neuromolecular Med"},{"issue":"9","key":"10.1016\/j.pharep.2015.12.008_bib1120","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.febslet.2009.10.058","article-title":"Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids","volume":"584","author":"Milhas","year":"2010","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1194\/jlr.M054627","article-title":"All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity","volume":"56","author":"Ding","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharep.2015.12.008_bib1130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1743-7075-8-89","article-title":"Subcellular targeting domains of sphingomyelin synthase 1 and 2","volume":"8","author":"Yeang","year":"2011","journal-title":"Nutr Metab (Lond)"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1135","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbalip.2008.07.002","article-title":"The domain responsible for sphingomyelin synthase (SMS) activity","volume":"1781","author":"Yeang","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.pharep.2015.12.008_bib1140","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bbalip.2007.05.007","article-title":"Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization","volume":"1771","author":"Li","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"10.1016\/j.pharep.2015.12.008_bib1145","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1074\/jbc.M702423200","article-title":"Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells","volume":"282","author":"Tafesse","year":"2007","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2015.12.008_bib1150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-015-2427-x","article-title":"Comparative analysis of sphingomyelin synthase 1 gene expression at the transcriptional and translational levels in human tissues","volume":"406","author":"Sudarkina","year":"2015","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.emboj.7600034","article-title":"Identification of a family of animal sphingomyelin synthases","volume":"23","author":"Huitema","year":"2004","journal-title":"EMBO J"},{"issue":"40","key":"10.1016\/j.pharep.2015.12.008_bib1160","doi-asserted-by":"crossref","first-page":"29421","DOI":"10.1074\/jbc.R600021200","article-title":"The multigenic sphingomyelin synthase family","volume":"281","author":"Tafesse","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1165","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s12035-014-8829-z","article-title":"Sphingomyelin synthase 1 regulates neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt signaling","volume":"51","author":"Wesley","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1170","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","article-title":"The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders","volume":"1841","author":"Taniguchi","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1175","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/cdd.2009.130","article-title":"Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death","volume":"17","author":"Lafont","year":"2010","journal-title":"Cell Death Differ"},{"issue":"16","key":"10.1016\/j.pharep.2015.12.008_bib1180","doi-asserted-by":"crossref","first-page":"12797","DOI":"10.1074\/jbc.M011570200","article-title":"Basic fibroblast growth factor-induced proliferation of primary astrocytes. Evidence for the involvement of sphingomyelin biosynthesis","volume":"276","author":"Riboni","year":"2001","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.pharep.2015.12.008_bib1185","doi-asserted-by":"crossref","first-page":"14550","DOI":"10.1074\/jbc.273.23.14550","article-title":"Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?","volume":"273","author":"Luberto","year":"1998","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1190","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1074\/jbc.272.11.6918","article-title":"Alteration of the sphingomyelin\/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity","volume":"272","author":"Cai","year":"1997","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1195","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2004-03-0900","article-title":"Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase","volume":"104","author":"Taguchi","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/intimm\/dxs008","article-title":"CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice","volume":"24","author":"Dong","year":"2012","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(98)00021-6","article-title":"Structure and functional properties of diacylglycerols in membranes","volume":"38","author":"Go\u00f1i","year":"1999","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1210","first-page":"573","article-title":"Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks","volume":"22","author":"Evangelisti","year":"2007","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1357-2725(98)00111-3","article-title":"Phosphatidylethanolamine and phosphatidylcholine are sources of diacylglycerol in ras-transformed NIH 3T3 fibroblasts","volume":"31","author":"Momchilova","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2009.02.063","article-title":"Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes","volume":"381","author":"Tani","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1225","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/ATVBAHA.108.168682","article-title":"Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation","volume":"28","author":"Hailemariam","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1230","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1194\/jlr.M900230-JLR200","article-title":"Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase","volume":"50","author":"Ternes","year":"2009","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1235","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2011.12.079","article-title":"Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation","volume":"417","author":"Kidani","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcp.2011.04.009","article-title":"The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain","volume":"82","author":"Zhang","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1245","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1083\/jcb.200903152","article-title":"Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER","volume":"185","author":"Vacaru","year":"2009","journal-title":"J Cell Biol"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1250","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1074\/jbc.273.7.4081","article-title":"Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling","volume":"273","author":"Marathe","year":"1998","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.pharep.2015.12.008_bib1255","doi-asserted-by":"crossref","first-page":"18431","DOI":"10.1074\/jbc.271.31.18431","article-title":"Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene","volume":"271","author":"Schissel","year":"1996","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2015.12.008_bib1260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1432-1033.1997.511_1a.x","article-title":"Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis","volume":"243","author":"Ferlinz","year":"1997","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1265","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1074\/jbc.273.5.2738","article-title":"Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development","volume":"273","author":"Schissel","year":"1998","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1270","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1016\/S0021-9258(18)83553-0","article-title":"A new Zn2+-stimulated sphingomyelinase in fetal bovine serum","volume":"264","author":"Spence","year":"1989","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1275","first-page":"205","article-title":"Sphingomyelinases, and Niemann\u2013Pick disease","volume":"24","author":"Levade","year":"1986","journal-title":"J Clin Chem Clin Biochem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.192.61","article-title":"Distribution of acid sphingomyelinase in human various body fluids","volume":"192","author":"Takahashi","year":"2000","journal-title":"Tohoku J Exp Med"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1285","doi-asserted-by":"crossref","first-page":"e62912","DOI":"10.1371\/journal.pone.0062912","article-title":"Characterization of acid sphingomyelinase activity in human cerebrospinal fluid","volume":"8","author":"M\u00fchle","year":"2013","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1290","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0049-3848(98)00033-4","article-title":"Sphingomyelinase activity in human platelets","volume":"90","author":"Simon","year":"1998","journal-title":"Thromb Res"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2015.12.008_bib1295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007041329052","article-title":"Characterization of sphingomyelinase activity released by thrombin-stimulated platelets","volume":"205","author":"Romiti","year":"2000","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1300","first-page":"217","article-title":"Sphingomyelinase increases 2-deoxyglucose uptake and glucose metabolism of human platelets","volume":"43","author":"Vasta","year":"1997","journal-title":"Biochem Mol Biol Int"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/ATVBAHA.112.300210","article-title":"Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation","volume":"34","author":"M\u00fcnzer","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/abbi.2000.2028","article-title":"Acceleration by ceramide of calcium-dependent translocation of phospholipase A2 from cytosol to membranes in platelets","volume":"382","author":"Kitatani","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1315","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.97.11.5895","article-title":"Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1320","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1073\/pnas.95.7.3638","article-title":"Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?","volume":"95","author":"Tomiuk","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.pharep.2015.12.008_bib1325","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1074\/jbc.M611249200","article-title":"Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization","volume":"282","author":"Tani","year":"2007","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1330","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuint.2005.06.011","article-title":"Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: implication for sensitivity to stress and inflammation","volume":"47","author":"Crivello","year":"2005","journal-title":"Neurochem Int"},{"issue":"12","key":"10.1016\/j.pharep.2015.12.008_bib1335","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1073\/pnas.0406380102","article-title":"Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development","volume":"102","author":"Stoffel","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1340","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1471-4159.2009.06038.x","article-title":"Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors","volume":"109","author":"Wheeler","year":"2009","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1345","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cellsig.2010.01.012","article-title":"Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium","volume":"22","author":"Kim","year":"2010","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1350","doi-asserted-by":"crossref","first-page":"H1421","DOI":"10.1152\/ajpheart.2000.278.5.H1421","article-title":"Sphingomyelinase ceramide analogs induce contraction and rises in [Ca(2+)](i) in canine cerebral vascular muscle","volume":"278","author":"Zheng","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1355","doi-asserted-by":"crossref","first-page":"F1178","DOI":"10.1152\/ajprenal.00079.2014","article-title":"Involvement of neutral sphingomyelinase in the angiotensin II signaling pathway","volume":"308","author":"Bautista-P\u00e9rez","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1360","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.febslet.2004.11.100","article-title":"Sphingomyelinase causes endothelium-dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca(2+) elevation","volume":"579","author":"Mogami","year":"2005","journal-title":"FEBS Lett"},{"issue":"12","key":"10.1016\/j.pharep.2015.12.008_bib1365","doi-asserted-by":"crossref","first-page":"e1004574","DOI":"10.1371\/journal.ppat.1004574","article-title":"Neutral sphingomyelinase in physiological and measles virus induced T cell suppression","volume":"10","author":"Mueller","year":"2014","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1370","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00018-014-1778-x","article-title":"Sphingolipid metabolism and its role in the skeletal tissues","volume":"72","author":"Khavandgar","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1375","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ng1603","article-title":"A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse","volume":"37","author":"Aubin","year":"2005","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2353\/ajpath.2007.061285","article-title":"Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression","volume":"171","author":"Stoffel","year":"2007","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1385","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1074\/jbc.275.8.5710","article-title":"Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase","volume":"275","author":"Tomiuk","year":"2000","journal-title":"J Biol Chem"},{"issue":"Pt 20","key":"10.1016\/j.pharep.2015.12.008_bib1390","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1242\/jcs.114.20.3727","article-title":"Nuclear localization of neutral sphingomyelinase 1: biochemical and immunocytochemical analyses","volume":"114","author":"Mizutani","year":"2001","journal-title":"J Cell Sci"},{"issue":"53","key":"10.1016\/j.pharep.2015.12.008_bib1395","doi-asserted-by":"crossref","first-page":"38131","DOI":"10.1074\/jbc.274.53.38131","article-title":"Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C","volume":"274","author":"Sawai","year":"1999","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1400","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/MCB.22.11.3633-3638.2002","article-title":"Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease","volume":"22","author":"Zumbansen","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1405","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1084\/jem.189.10.1581","article-title":"A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction","volume":"189","author":"Tonnetti","year":"1999","journal-title":"J Exp Med"},{"issue":"44","key":"10.1016\/j.pharep.2015.12.008_bib1410","doi-asserted-by":"crossref","first-page":"29971","DOI":"10.1074\/jbc.M805402200","article-title":"Identification of Mg2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis","volume":"283","author":"Yabu","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1415","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2014.128","article-title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling","volume":"22","author":"Yabu","year":"2015","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1420","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1074\/jbc.M114.605253","article-title":"The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes","volume":"290","author":"Guo","year":"2015","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.pharep.2015.12.008_bib1425","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1074\/jbc.M511306200","article-title":"Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein","volume":"281","author":"Krut","year":"2006","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1430","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1541-7786.MCR-07-2097","article-title":"Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies","volume":"6","author":"Corcoran","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.pharep.2015.12.008_bib1435","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.redox.2014.07.006","article-title":"Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle","volume":"2","author":"Moylan","year":"2014","journal-title":"Redox Biol"},{"issue":"23","key":"10.1016\/j.pharep.2015.12.008_bib1440","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1074\/jbc.M110.102988","article-title":"Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1445","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbagen.2014.11.019","article-title":"Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization","volume":"1850","author":"Rajagopalan","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 3","key":"10.1016\/j.pharep.2015.12.008_bib1450","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/BJ20041627","article-title":"A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria","volume":"386","author":"Birbes","year":"2005","journal-title":"Biochem J"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1455","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1194\/jlr.M800159-JLR200","article-title":"Lipid levels in sperm, eggs, and during fertilization in Xenopus laevis","volume":"49","author":"Petcoff","year":"2008","journal-title":"J Lipid Res"},{"issue":"25","key":"10.1016\/j.pharep.2015.12.008_bib1460","doi-asserted-by":"crossref","first-page":"18151","DOI":"10.1074\/jbc.M700709200","article-title":"Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa","volume":"282","author":"Furland","year":"2007","journal-title":"J Biol Chem"},{"issue":"40","key":"10.1016\/j.pharep.2015.12.008_bib1465","doi-asserted-by":"crossref","first-page":"38528","DOI":"10.1074\/jbc.M305437200","article-title":"Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family","volume":"278","author":"Duan","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1470","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.510260403","article-title":"Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity","volume":"26","author":"Duan","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1475","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0955-2863(97)00010-7","article-title":"Localization and capacity of sphingomyelin digestion in the rat intestinal tract","volume":"8","author":"Nyberg","year":"1997","journal-title":"J Nutr Biochem"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1480","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/01616412.1996.11740432","article-title":"Sphingomyelin changes in rat cerebral cortex during focal ischemia","volume":"18","author":"Kubota","year":"1996","journal-title":"Neurol Res"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2015.12.008_bib1485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(00)01655-4","article-title":"Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus","volume":"296","author":"Nakane","year":"2000","journal-title":"Neurosci Lett"},{"issue":"13\u201314","key":"10.1016\/j.pharep.2015.12.008_bib1490","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/02699050903379388","article-title":"Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia","volume":"23","author":"Tian","year":"2009","journal-title":"Brain Inj"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1495","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuint.2004.04.001","article-title":"Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress","volume":"45","author":"Soeda","year":"2004","journal-title":"Neurochem Int"},{"issue":"51","key":"10.1016\/j.pharep.2015.12.008_bib1500","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.273.51.34472","article-title":"Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain","volume":"273","author":"Liu","year":"1998","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharep.2015.12.008_bib1505","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1074\/jbc.273.12.6921","article-title":"Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation","volume":"273","author":"Yoshimura","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1510","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1471-4159.1999.0730675.x","article-title":"Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death","volume":"73","author":"Yoshimura","year":"1999","journal-title":"J Neurochem"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1515","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1074\/jbc.275.11.7641","article-title":"Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain","volume":"275","author":"Bernardo","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2015.12.008_bib1520","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1742-2094-10-109","article-title":"Early activation of nSMase2\/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi","volume":"10","author":"Gu","year":"2013","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2004.07.024","article-title":"Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia","volume":"1023","author":"Ohtani","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2015.12.008_bib1530","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4172\/2161-0460.1000139","article-title":"Calpain-mediated Hsp70.1 cleavage in monkey CA1 after ischemia induces similar \u2018lysosomal vesiculosis\u2019 to Alzheimer neurons","volume":"4","author":"Yamashima","year":"2014","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1535","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/JMN:15:2:85","article-title":"Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis","volume":"15","author":"Yu","year":"2000","journal-title":"J Mol Neurosci"},{"issue":"35","key":"10.1016\/j.pharep.2015.12.008_bib1540","doi-asserted-by":"crossref","first-page":"25940","DOI":"10.1074\/jbc.M701812200","article-title":"JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction","volume":"282","author":"Yu","year":"2007","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1016\/j.pharep.2015.12.008_bib1545","doi-asserted-by":"crossref","first-page":"26509","DOI":"10.1074\/jbc.M801597200","article-title":"Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia\/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells","volume":"283","author":"Jin","year":"2008","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.pharep.2015.12.008_bib1550","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.neurobiolaging.2014.02.025","article-title":"Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia","volume":"35","author":"Lam","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1555","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"J Biol Chem"},{"issue":"34","key":"10.1016\/j.pharep.2015.12.008_bib1560","doi-asserted-by":"crossref","first-page":"30022","DOI":"10.1074\/jbc.M111.261206","article-title":"Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels","volume":"286","author":"Ben-David","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1565","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0092-8674(00)80169-5","article-title":"FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase","volume":"86","author":"Adam-Klages","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1570","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1073\/pnas.0908486107","article-title":"The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase","volume":"107","author":"Philipp","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1575","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1165\/ajrcmb.25.6.4321","article-title":"Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione","volume":"25","author":"Lavrentiadou","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1580","doi-asserted-by":"crossref","first-page":"41","DOI":"10.6030\/1939-067X-2.2.41","article-title":"Vitamin E regulates SMase activity, GSH levels, and inhibits neuronal death in stroke-prone spontaneously hypertensive rats during hypoxia and reoxygenation","volume":"2","author":"Yamagata","year":"2009","journal-title":"J Exp Stroke Transl Med"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1585","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.freeradbiomed.2006.01.035","article-title":"Sphingolipid signaling and redox regulation","volume":"40","author":"Won","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1590","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1159\/000341460","article-title":"Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase","volume":"30","author":"Li","year":"2012","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1595","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4049\/jimmunol.1103721","article-title":"Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation","volume":"190","author":"Wei","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.pharep.2015.12.008_bib1600","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainres.2007.10.056","article-title":"Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia","volume":"1188","author":"Dmitrieva","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2015.12.008_bib1605","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jnr.10355","article-title":"Alzheimer's disease: beta-amyloid protein and tau","volume":"70","author":"Morishima-Kawashima","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharep.2015.12.008_bib1610","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer's disease","volume":"1","author":"Ore\u0161i\u010d","year":"2011","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1615","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neurobiolaging.2008.03.011","article-title":"Serum sphingomyelins and ceramides are early predictors of memory impairment","volume":"31","author":"Mielke","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1620","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"issue":"7\u20138","key":"10.1016\/j.pharep.2015.12.008_bib1625","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00216-010-4273-8","article-title":"Nano-HPLC\u2013MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients \u2013 a pilot study","volume":"398","author":"Kosicek","year":"2010","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1630","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neulet.2012.04.019","article-title":"Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease","volume":"516","author":"Kosicek","year":"2012","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1635","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.neurobiolaging.2014.05.019","article-title":"Cerebrospinal fluid sphingolipids, \u03b2-amyloid, and tau in adults at risk for Alzheimer's disease","volume":"35","author":"Mielke","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1640","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002093-199601020-00004","article-title":"Reductions in membrane proteins and lipids in basal ganglia of classic Alzheimer disease patients","volume":"10","author":"Gottfries","year":"1996","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1645","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1471-4159.1992.tb10994.x","article-title":"Lipid composition in different regions of the brain in Alzheimer's disease\/senile dementia of Alzheimer's type","volume":"59","author":"S\u00f6derberg","year":"1992","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1650","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer's disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharep.2015.12.008_bib1655","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1043-6618(03)00052-5","article-title":"Regulation of death receptor signaling and apoptosis by ceramide","volume":"47","author":"Gulbins","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2015.12.008_bib1660","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2014.01.010","article-title":"Ceramides and sphingomyelinases in senile plaques","volume":"65","author":"Panchal","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"12 Pt A","key":"10.1016\/j.pharep.2015.12.008_bib1665","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.bbadis.2014.09.014","article-title":"Region-specific metabolic alterations in the brain of the APP\/PS1 transgenic mice of Alzheimer's disease","volume":"1842","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharep.2015.12.008_bib1670","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer's disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1675","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09687860500496417","article-title":"The involvement of lipid rafts in Alzheimer's disease","volume":"23","author":"Cordy","year":"2006","journal-title":"Mol Membr Biol"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2015.12.008_bib1680","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainresbull.2010.02.013","article-title":"Lipid rafts: keys to neurodegeneration","volume":"82","author":"Schengrund","year":"2010","journal-title":"Brain Res Bull"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1685","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.neurobiolaging.2014.02.005","article-title":"Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP\/BACE1 interactions","volume":"35","author":"Fabelo","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1690","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3233\/JAD-141146","article-title":"Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1\/A\u03b2PP interaction in early stages of Alzheimer's disease","volume":"43","author":"D\u00edaz","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.pharep.2015.12.008_bib1695","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.freeradbiomed.2010.02.008","article-title":"Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein","volume":"48","author":"Clement","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1700","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.freeradbiomed.2004.04.007","article-title":"Inflammatory mediator and beta-amyloid (25e35)-induced ceramide generation and iNOS expression are inhibited by vitamin E","volume":"37","author":"Ayasolla","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1705","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","article-title":"Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin","volume":"7","author":"Grimm","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1710","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","article-title":"Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease","volume":"35","author":"Dinkins","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"14","key":"10.1016\/j.pharep.2015.12.008_bib1715","doi-asserted-by":"crossref","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","article-title":"Sphingolipid-modulated exosome secretion promotes clearance of amyloid-\u03b2 by microglia","volume":"287","author":"Yuyama","year":"2012","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1720","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20132451","article-title":"Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease","volume":"211","author":"Lee","year":"2014","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1725","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neurobiolaging.2007.07.024","article-title":"ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain","volume":"30","author":"Bandaru","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1730","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0447.1997.tb09622.x","article-title":"Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers","volume":"95","author":"Maes","year":"1997","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1735","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archpsyc.55.7.580","article-title":"The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment","volume":"55","author":"Musselman","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.pharep.2015.12.008_bib1740","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1043-2760(01)00407-6","article-title":"Depression: a major, unrecognized risk factor for osteoporosis?","volume":"12","author":"Cizza","year":"2001","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1745","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jpsychires.2012.11.001","article-title":"Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study","volume":"47","author":"Demirkan","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.pharep.2015.12.008_bib1750","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00702-005-0374-5","article-title":"High activity of acid sphingomyelinase in major depression","volume":"112","author":"Kornhuber","year":"2005","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.pharep.2015.12.008_bib1755","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2015.02.027","article-title":"Time-dependent modulation of glutamate synapses onto 5-HT neurons by antidepressant treatment","volume":"95","author":"Geddes","year":"2015","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1760","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0149-7634(02)00005-2","article-title":"Tianeptine: 5-HT uptake sites and 5-HT(1\u20137) receptors modulate memory formation in an autoshaping Pavlovian\/instrumental task","volume":"26","author":"Meneses","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1765","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-201X.2007.01687.x","article-title":"Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells","volume":"190","author":"Sj\u00f6gren","year":"2007","journal-title":"Acta Physiol (Oxf)"},{"issue":"16","key":"10.1016\/j.pharep.2015.12.008_bib1770","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/rcm.7241","article-title":"Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"29","author":"Weng","year":"2015","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1775","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000315101","article-title":"Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications","volume":"26","author":"Kornhuber","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1780","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1785","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(93)90032-C","article-title":"Erythrocyte membrane phospholipids in psychotic patients","volume":"49","author":"Keshavan","year":"1993","journal-title":"Psychiatry Res"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2015.12.008_bib1790","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0920-9964(00)00189-4","article-title":"Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology","volume":"52","author":"Ponizovsky","year":"2001","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1795","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2004.03.019","article-title":"Altered thalamic membrane phospholipids in schizophrenia: a postmortem study","volume":"56","author":"Schmitt","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"Pt 13","key":"10.1016\/j.pharep.2015.12.008_bib1800","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1113\/jphysiol.2011.209494","article-title":"\u03b17 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane","volume":"589","author":"Col\u00f3n-S\u00e1ez","year":"2011","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.pharep.2015.12.008_bib1805","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1810","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4161\/auto.6685","article-title":"Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis","volume":"4","author":"Xilouri","year":"2008","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.pharep.2015.12.008_bib1815","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.parkreldis.2015.06.016","article-title":"The contribution of Niemann\u2013Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews","volume":"21","author":"Dagan","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.pharep.2015.12.008_bib1820","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.06.010","article-title":"Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease","volume":"34","author":"Foo","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"17","key":"10.1016\/j.pharep.2015.12.008_bib1825","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","article-title":"The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease","volume":"80","author":"Gan-Or","year":"2013","journal-title":"Neurology"},{"issue":"1672","key":"10.1016\/j.pharep.2015.12.008_bib1830","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0187","article-title":"Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission","volume":"370","author":"Das","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"16","key":"10.1016\/j.pharep.2015.12.008_bib1835","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.jmb.2013.04.002","article-title":"Solid-state 13C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein \u03b1-Synuclein","volume":"425","author":"Leftin","year":"2013","journal-title":"J Mol Biol"},{"issue":"17","key":"10.1016\/j.pharep.2015.12.008_bib1840","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.pharep.2015.12.008_bib1845","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.26278","article-title":"No evidence for substrate accumulation in Parkinson brains with GBA mutations","volume":"30","author":"Gegg","year":"2015","journal-title":"Mov Disord"},{"issue":"9\u201310","key":"10.1016\/j.pharep.2015.12.008_bib1850","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1855","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharep.2015.12.008_bib1860","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl Neurodegener"},{"issue":"14","key":"10.1016\/j.pharep.2015.12.008_bib1865","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1870","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/abio.2001.5108","article-title":"An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann\u2013Pick disease","volume":"293","author":"He","year":"2001","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.pharep.2015.12.008_bib1875","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.cdd.4400775","article-title":"Disease versus acid sphingomyelinase deficiency","volume":"8","author":"Lozano","year":"2001","journal-title":"Cell Death Differ"},{"issue":"9","key":"10.1016\/j.pharep.2015.12.008_bib1880","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1073\/pnas.88.9.3748","article-title":"A frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients","volume":"88","author":"Levran","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1885","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/345074","article-title":"The demographics and distribution of type B Niemann\u2013Pick disease: novel mutations lead to new genotype\/phenotype correlations","volume":"71","author":"Simonaro","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharep.2015.12.008_bib1890","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/8904_2011_80","article-title":"Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing Niemann\u2013Pick disease","volume":"3","author":"T\u00f3th","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.pharep.2015.12.008_bib1895","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-8-15","article-title":"Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann\u2013Pick disease","volume":"8","author":"Zhang","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1900","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cge.12076","article-title":"Identification of seven novel SMPD1 mutations causing Niemann\u2013Pick disease types A and B","volume":"84","author":"Irun","year":"2013","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1905","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.3390\/ijms16046668","article-title":"Four novel p.N385K, p.V36A, c.1033-1034insT and c.1417-1418delCT mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene in patients with types A and B Niemann\u2013Pick disease (NPD)","volume":"16","author":"Manshadi","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pharep.2015.12.008_bib1910","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","article-title":"Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol","volume":"137","author":"Kwon","year":"2009","journal-title":"Cell"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2015.12.008_bib1915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbalip.2004.08.007","article-title":"Structure and function of the NPC2 protein","volume":"1685","author":"Vanier","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1920","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01800716","article-title":"Correction of sphingomyelinase deficiency in Niemann\u2013Pick type C fibroblasts by removal of lipoprotein fraction from culture media","volume":"12","author":"Thomas","year":"1989","journal-title":"J Inherit Metab Dis"},{"issue":"23","key":"10.1016\/j.pharep.2015.12.008_bib1925","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","article-title":"A defect in cholesterol esterification in Niemann\u2013Pick disease (type C) patients","volume":"82","author":"Pentchev","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1930","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","article-title":"Natural history of type A Niemann\u2013Pick disease; possible endpoints for therapeutic trials","volume":"66","author":"McGovern","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1935","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann\u2013Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.pharep.2015.12.008_bib1940","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1067\/mpd.2003.113","article-title":"Growth restriction in children with type B Niemann\u2013Pick disease","volume":"142","author":"Wasserstein","year":"2003","journal-title":"J Pediatr"},{"issue":"13","key":"10.1016\/j.pharep.2015.12.008_bib1945","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/hmg\/9.13.1967","volume":"9","author":"Marathe","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.pharep.2015.12.008_bib1950","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/cdd.2014.4","article-title":"High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A","volume":"21","author":"Gaband\u00e9-Rodr\u00edguez","year":"2014","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1955","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.expneurol.2008.07.026","article-title":"Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann\u2013Pick A disease including structure\u2013function studies associated with cerebellar Purkinje cell degeneration","volume":"214","author":"Macauley","year":"2008","journal-title":"Exp Neurol"},{"issue":"13","key":"10.1016\/j.pharep.2015.12.008_bib1960","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann\u2013Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1965","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2008.10.021","article-title":"Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann\u2013Pick A disease","volume":"215","author":"Dodge","year":"2009","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2015.12.008_bib1970","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2014.07.005","article-title":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: the utility of animal models of disease in the toxicological evaluation of potential therapeutics","volume":"114","author":"Murray","year":"2015","journal-title":"Mol Genet Metab"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:22Z","timestamp":1752611782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.12.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":197,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1734114016000025"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.12.008","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of sphingomyelin metabolism","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}